Backpage: Nailing Down DTC Promotion - Pharmaceutical Executive


Backpage: Nailing Down DTC Promotion
Before FDA and industry can find a solution to DTC promotion, they need to nail down the problem.

Pharmaceutical Executive

Questions Left Unanswered Despite FDA holding hearings, and PhRMA issuing guidelines to help diminish controversial promotional activity, it remains unclear what specific problem needs to be addressed in order to improve industry's use of direct-to-consumer marketing.

Lou Morris is president of Louis A. Morris & Associates. He can be reached at


blog comments powered by Disqus

Source: Pharmaceutical Executive,
Click here